SLC38A5 and breast carcinoma: Further studies revealed that pretreatment of TNBC cells with niclosamide reduces the protein expression of SLC38A5 and SLC7A11, induces oxidative stress, lipid peroxidation, and ferroptosis, and significantly suppresses breast cancer growth in mouse xenograft models (Mathew et al., 2024).